Epidemiologic Study of Reproductive Outcome in Women With Systemic Lupus Erythematosus
NCT00004663 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 480
Last updated 2005-06-24
Summary
OBJECTIVES: I. Evaluate whether pregnancy is an independent risk factor that affects disease activity in women with systemic lupus erythematosus.
II. Evaluate whether maternal disease activity is a risk factor for adverse pregnancy outcome.
Conditions
Sponsors & Collaborators
-
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
collaborator NIH - collaborator OTHER
-
National Center for Research Resources (NCRR)
lead NIH
Principal Investigators
-
Rosalind Ramsey-Goldman · Northwestern University
Eligibility
- Min Age
- 18 Years
- Max Age
- 50 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 1994-02-28
More Related Trials
-
Serologically Active, Clinically Stable Systemic Lupus Erythematosus
NCT00000421 ·Status: COMPLETED ·Phase: PHASE2
-
SLE Therapy Changes in Pregnancy and Relation to Pregnancy Outcome
NCT05176041 ·Status: COMPLETED
-
Phase II Pilot Study of Cytarabine for Refractory Systemic Lupus Erythematosus
NCT00004643 ·Status: COMPLETED ·Phase: PHASE2
-
Phase II Study of Long-Term Dehydroepiandrosterone for Systemic Lupus Erythematosus
NCT00004665 ·Status: COMPLETED ·Phase: PHASE2
-
Phase III Randomized, Double-Blind, Placebo-Controlled Study of Dehydroepiandrosterone in Women With Active Systemic Lupus Erythematosus
NCT00004662 ·Status: COMPLETED ·Phase: PHASE3
-
Disease Progression and Activity in Patients With Systemic Lupus Erythematosus
NCT00339261 ·Status: COMPLETED
-
Anifrolumab Pregnancy Study
NCT07049653 ·Status: NOT_YET_RECRUITING
-
Immune Ablation and Hematopoietic Stem Cell Support in Patients With Systemic Lupus Erythematosus: A Phase II Study
NCT00271934 ·Status: COMPLETED ·Phase: PHASE2
-
Predictors of Remission and Renal Outcomes in Lupus Nephritis in Assuit University Hospitals.
NCT06228222 ·Status: NOT_YET_RECRUITING
-
GENetic & Immunologic Abnomalies in Systemic Lupus Erythematosus
NCT01992666 ·Status: COMPLETED ·Phase: NA
-
Study of the Predictors of the Course and Early Outcome of Patients With Systemic Lupus Erythematosus: Nature Versus Nurture
NCT00006134 ·Status: COMPLETED
-
A Study of Skin and Systemic Biomarkers In Patients With Active Cutaneous Lupus Erythematosus And In Healthy Volunteers
NCT02034344 ·Status: COMPLETED
-
Lupus Cohort--Thrombotic Events and Coronary Artery Disease
NCT00005436 ·Status: COMPLETED
-
Effect of Simvastatin on Endothelial Function in Premenopausal Women With Systemic Lupus Erythematosus (0733-271)(TERMINATED)
NCT00739050 ·Status: TERMINATED ·Phase: PHASE4
-
Safety of Estrogens in Lupus: Birth Control Pills
NCT00000420 ·Status: COMPLETED ·Phase: PHASE3
-
Cardiac and Laboratory Findings in Patients With Systemic Lupus Erythematosus
NCT03179046 ·Status: COMPLETED
-
Prospective Registry Investigating Maternal and Infant Outcomes in Anifrolumab Users
NCT06659029 ·Status: RECRUITING
-
Gynecological Symptoms and Health-related Quality of Life in Egyptian Women With SLE
NCT05230316 ·Status: UNKNOWN
-
Gut Microbiota Dysbiosis in Lupus Nephritis
NCT06231303 ·Status: NOT_YET_RECRUITING
-
Study on the Safety for the Newborn of the Use of Biologics During Pregnancy by Mothers Affected by Autoimmune Diseases
NCT04197232 ·Status: RECRUITING
-
Association of Serum Interleukin-33 Levels With Clinical Manifestations in Systemic Lupus Erythematosus
NCT07149402 ·Status: NOT_YET_RECRUITING
-
Subcutaneous Treatment In Randomized Subjects To Evaluate Safety And Efficacy In Generalized Lupus Erythematosus
NCT01405196 ·Status: COMPLETED ·Phase: PHASE2
-
New Signaling Pathway Targeting Systemic Lupus Erythematosus
NCT03984227 ·Status: UNKNOWN
-
The Research Registry for Neonatal Lupus
NCT00074373 ·Status: COMPLETED
-
Subgrouping SLE - a New Approach to Understand the Pathogenesis and Improve Treatment
NCT07102030 ·Status: RECRUITING